Pfizer Inc
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Finite-lived intangible assets by Year
Finite-lived intangible assets — Accumulated amortization ($M) ($M)
Pfizer Finite-lived intangible assets: $72,496M in FY2025, up 7.3% from a year earlier. That is the highest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-04) ↗
Reported in Form 10-Q / 10-K Goodwill & Other Intangible Assets Footnote.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Finite-lived intangible assets — Accumulated amortization ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 72,496 | +7.3% | Form 10-Q (filed 2026-08-04) ↗ |
| FY2024 | Dec 31, 2024 | 67,549 | +7.5% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 62,828 | +7.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 58,548 | +4.9% | Form 10-K (filed 2024-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 55,838 | +6.4% | Form 10-K (filed 2023-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 52,493 | +7.3% | Form 10-K (filed 2022-02-24) ↗ |
| FY2019 | Dec 31, 2019 | 48,941 | -19.4% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 60,743 | +6.5% | Form 10-K (filed 2020-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 57,033 | +10.3% | Form 10-K (filed 2019-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 51,687 | +5.4% | Form 10-K (filed 2018-02-22) ↗ |
| FY2015 | Dec 31, 2015 | 49,040 | – | Form 10-K (filed 2017-02-23) ↗ |
Cite this data
StockData. (2026). Pfizer Finite-lived intangible assets ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/intang-accum-tot
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.